Alexander & Baldwin insider files Form 144 to sell 700 common shares
Rhea-AI Filing Summary
Alexander & Baldwin, Inc. (ALEX) Form 144 reports a proposed sale of 700 common shares through UBS Financial Services with an aggregate market value of $12,740.00. The filing lists 72,753,270 shares outstanding and an approximate sale date of 08/11/2025.
The securities were acquired as compensation from the issuer on 02/01/2023. The filing also discloses three recent sales by The Meredith J Ching Revocable Living Trust of 700 shares each on 05/12/2025, 06/10/2025 and 07/10/2025 with gross proceeds of $12,451.04, $12,862.99 and $12,552.05, respectively.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine insider sale; unlikely to move valuation materially.
The Form 144 documents a proposed sale of 700 common shares valued at $12,740, a nominal amount relative to the 72.75 million shares outstanding noted on the form. The shares were acquired as compensation on 02/01/2023, and the filer has recorded three similar 700-share disposals in the prior three months. From a market-impact perspective, these transactions are immaterial in size and consistent with routine insider liquidity rather than a company-specific capital event.
TL;DR: Repeated small sales show a pattern of limited insider disposals, not a clear governance concern.
The filing shows repeated, modest dispositions by or for a related trust across May–July 2025 and a further proposed sale for 08/11/2025. The shares were granted as compensation in February 2023, suggesting these are personal or trust-level liquidity actions rather than corporate transactions. No information in the filing indicates undisclosed material nonpublic information or a change in corporate control; disclosures on the form are routine and consistent with Rule 144 reporting.